Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies

Isabel Campos-pinto, Lucía Méndez, James Schouten, John Wilkins, Maria Fedorova, Andrew Pitt, Paul Davis, Corinne Spickett

Research output: Contribution to journalArticle

Abstract

Lipids are susceptible to damage by reactive oxygen species, and from lipid oxidation reactions many short chain lipid peroxidation products can be formed. 4-Hydroxy-2-nonenal (HNE) is one of the most abundant and cytotoxic lipid oxidation products and is known to form covalent adducts with nucleophilic amino acids of proteins. HNE-modified proteins have value as biomarkers and can be detected by antibody-based techniques, but most commercially available antibodies were raised against HNE-keyhole limpet hemocyanin. We used HNE-treated human serum albumin (HSA) to raise sheep antiserum and report for the first time the use of covalently modified peptide arrays to assess epitope binding of antibodies (Abs). Peptide arrays covering the sequence of HSA and treated post peptide synthesis with HNE were used to compare the different binding patterns of a commercial polyclonal antibody (pAb) raised against HNE-treated KLH and an in-house anti-HNE enriched pAb. The results were correlated with analysis of HNE-modified HSA by high-resolution tandem mass spectrometry. Both anti-HNE pAbs were found to bind strongly to eight common peptides on the HNE-treated HSA membranes, suggesting that HNE adducts per se induced an immune response in both cases even though different immunogens were used. Both antibodies bound with the highest affinity to the peptide 365DPHECYAKVFDEFKPLV381, which contains K378 and was also shown to be modified by the mass spectrometry analysis. Overall, the commercial anti-HNE pAb showed better specificity, recognizing nine out of the eleven adducts found by MS/MS, while the in-house enriched pAb only recognizes six. Nevertheless, the in-house pAb recognized specific peptides that were not recognized by the commercial pAb, which suggests the presence of clones uniquely specific to HNE adducts on HSA.
Original languageEnglish
Pages (from-to)234-244
Number of pages11
JournalFree Radical Biology and Medicine
Volume144
Early online date7 May 2019
DOIs
Publication statusPublished - 20 Nov 2019

Fingerprint

Epitope Mapping
Serum Albumin
Epitopes
Antibodies
Peptides
Lipids
Mass spectrometry
2-nonenal
4-hydroxy-2-nonenal
Oxidation
Biomarkers
Tandem Mass Spectrometry
Lipid Peroxidation
Immune Sera
Reactive Oxygen Species
Mass Spectrometry
Sheep
Proteins

Bibliographical note

© 2019 The Authors. Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)

Funding: European Union’s Horizon 2020 research and innovation programme under the MASSTRPLAN Marie Sklowdowska-Curie grant agreement number 67513. The financial support from German Federal Ministry of Education and Research (BMBF); Xunta de Galicia postdoctoral scholarship.

Keywords

  • Antibodies
  • Diagnostics
  • Epitope mapping
  • Lipid peroxidation
  • Mass spectrometry
  • Peptide arrays
  • Protein lipoxidation

Cite this

Campos-pinto, Isabel ; Méndez, Lucía ; Schouten, James ; Wilkins, John ; Fedorova, Maria ; Pitt, Andrew ; Davis, Paul ; Spickett, Corinne. / Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies. In: Free Radical Biology and Medicine. 2019 ; Vol. 144. pp. 234-244.
@article{3400ca1afc274eb386ceb0e9f1711fe3,
title = "Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies",
abstract = "Lipids are susceptible to damage by reactive oxygen species, and from lipid oxidation reactions many short chain lipid peroxidation products can be formed. 4-Hydroxy-2-nonenal (HNE) is one of the most abundant and cytotoxic lipid oxidation products and is known to form covalent adducts with nucleophilic amino acids of proteins. HNE-modified proteins have value as biomarkers and can be detected by antibody-based techniques, but most commercially available antibodies were raised against HNE-keyhole limpet hemocyanin. We used HNE-treated human serum albumin (HSA) to raise sheep antiserum and report for the first time the use of covalently modified peptide arrays to assess epitope binding of antibodies (Abs). Peptide arrays covering the sequence of HSA and treated post peptide synthesis with HNE were used to compare the different binding patterns of a commercial polyclonal antibody (pAb) raised against HNE-treated KLH and an in-house anti-HNE enriched pAb. The results were correlated with analysis of HNE-modified HSA by high-resolution tandem mass spectrometry. Both anti-HNE pAbs were found to bind strongly to eight common peptides on the HNE-treated HSA membranes, suggesting that HNE adducts per se induced an immune response in both cases even though different immunogens were used. Both antibodies bound with the highest affinity to the peptide 365DPHECYAKVFDEFKPLV381, which contains K378 and was also shown to be modified by the mass spectrometry analysis. Overall, the commercial anti-HNE pAb showed better specificity, recognizing nine out of the eleven adducts found by MS/MS, while the in-house enriched pAb only recognizes six. Nevertheless, the in-house pAb recognized specific peptides that were not recognized by the commercial pAb, which suggests the presence of clones uniquely specific to HNE adducts on HSA.",
keywords = "Antibodies, Diagnostics, Epitope mapping, Lipid peroxidation, Mass spectrometry, Peptide arrays, Protein lipoxidation",
author = "Isabel Campos-pinto and Luc{\'i}a M{\'e}ndez and James Schouten and John Wilkins and Maria Fedorova and Andrew Pitt and Paul Davis and Corinne Spickett",
note = "{\circledC} 2019 The Authors. Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) Funding: European Union’s Horizon 2020 research and innovation programme under the MASSTRPLAN Marie Sklowdowska-Curie grant agreement number 67513. The financial support from German Federal Ministry of Education and Research (BMBF); Xunta de Galicia postdoctoral scholarship.",
year = "2019",
month = "11",
day = "20",
doi = "10.1016/j.freeradbiomed.2019.05.008",
language = "English",
volume = "144",
pages = "234--244",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier",

}

Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies. / Campos-pinto, Isabel; Méndez, Lucía; Schouten, James; Wilkins, John; Fedorova, Maria; Pitt, Andrew; Davis, Paul; Spickett, Corinne.

In: Free Radical Biology and Medicine, Vol. 144, 20.11.2019, p. 234-244.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies

AU - Campos-pinto, Isabel

AU - Méndez, Lucía

AU - Schouten, James

AU - Wilkins, John

AU - Fedorova, Maria

AU - Pitt, Andrew

AU - Davis, Paul

AU - Spickett, Corinne

N1 - © 2019 The Authors. Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) Funding: European Union’s Horizon 2020 research and innovation programme under the MASSTRPLAN Marie Sklowdowska-Curie grant agreement number 67513. The financial support from German Federal Ministry of Education and Research (BMBF); Xunta de Galicia postdoctoral scholarship.

PY - 2019/11/20

Y1 - 2019/11/20

N2 - Lipids are susceptible to damage by reactive oxygen species, and from lipid oxidation reactions many short chain lipid peroxidation products can be formed. 4-Hydroxy-2-nonenal (HNE) is one of the most abundant and cytotoxic lipid oxidation products and is known to form covalent adducts with nucleophilic amino acids of proteins. HNE-modified proteins have value as biomarkers and can be detected by antibody-based techniques, but most commercially available antibodies were raised against HNE-keyhole limpet hemocyanin. We used HNE-treated human serum albumin (HSA) to raise sheep antiserum and report for the first time the use of covalently modified peptide arrays to assess epitope binding of antibodies (Abs). Peptide arrays covering the sequence of HSA and treated post peptide synthesis with HNE were used to compare the different binding patterns of a commercial polyclonal antibody (pAb) raised against HNE-treated KLH and an in-house anti-HNE enriched pAb. The results were correlated with analysis of HNE-modified HSA by high-resolution tandem mass spectrometry. Both anti-HNE pAbs were found to bind strongly to eight common peptides on the HNE-treated HSA membranes, suggesting that HNE adducts per se induced an immune response in both cases even though different immunogens were used. Both antibodies bound with the highest affinity to the peptide 365DPHECYAKVFDEFKPLV381, which contains K378 and was also shown to be modified by the mass spectrometry analysis. Overall, the commercial anti-HNE pAb showed better specificity, recognizing nine out of the eleven adducts found by MS/MS, while the in-house enriched pAb only recognizes six. Nevertheless, the in-house pAb recognized specific peptides that were not recognized by the commercial pAb, which suggests the presence of clones uniquely specific to HNE adducts on HSA.

AB - Lipids are susceptible to damage by reactive oxygen species, and from lipid oxidation reactions many short chain lipid peroxidation products can be formed. 4-Hydroxy-2-nonenal (HNE) is one of the most abundant and cytotoxic lipid oxidation products and is known to form covalent adducts with nucleophilic amino acids of proteins. HNE-modified proteins have value as biomarkers and can be detected by antibody-based techniques, but most commercially available antibodies were raised against HNE-keyhole limpet hemocyanin. We used HNE-treated human serum albumin (HSA) to raise sheep antiserum and report for the first time the use of covalently modified peptide arrays to assess epitope binding of antibodies (Abs). Peptide arrays covering the sequence of HSA and treated post peptide synthesis with HNE were used to compare the different binding patterns of a commercial polyclonal antibody (pAb) raised against HNE-treated KLH and an in-house anti-HNE enriched pAb. The results were correlated with analysis of HNE-modified HSA by high-resolution tandem mass spectrometry. Both anti-HNE pAbs were found to bind strongly to eight common peptides on the HNE-treated HSA membranes, suggesting that HNE adducts per se induced an immune response in both cases even though different immunogens were used. Both antibodies bound with the highest affinity to the peptide 365DPHECYAKVFDEFKPLV381, which contains K378 and was also shown to be modified by the mass spectrometry analysis. Overall, the commercial anti-HNE pAb showed better specificity, recognizing nine out of the eleven adducts found by MS/MS, while the in-house enriched pAb only recognizes six. Nevertheless, the in-house pAb recognized specific peptides that were not recognized by the commercial pAb, which suggests the presence of clones uniquely specific to HNE adducts on HSA.

KW - Antibodies

KW - Diagnostics

KW - Epitope mapping

KW - Lipid peroxidation

KW - Mass spectrometry

KW - Peptide arrays

KW - Protein lipoxidation

UR - https://linkinghub.elsevier.com/retrieve/pii/S0891584919303545

UR - http://www.scopus.com/inward/record.url?scp=85066780201&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2019.05.008

DO - 10.1016/j.freeradbiomed.2019.05.008

M3 - Article

VL - 144

SP - 234

EP - 244

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -